{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:10:45Z","timestamp":1791641445717,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genetic mutations in the\n                    <jats:italic>MYBPC3<\/jats:italic>\n                    gene encoding cardiac myosin binding protein C (cMyBP-C) are the most common cause of hypertrophic cardiomyopathy (HCM). Myocardial fibrosis (MF) plays a critical role in the development of HCM. However, the mechanism for mutant\n                    <jats:italic>MYBPC3<\/jats:italic>\n                    -induced MF is not well defined. In this study, we developed a R495Q mutant pig model using cytosine base editing and observed an early-onset MF in these mutant pigs shortly after birth. Unexpectedly, we found that the \u201ccardiac-specific\u201d\n                    <jats:italic>MYBPC3<\/jats:italic>\n                    gene was actually expressed in cardiac fibroblasts from different species as well as NIH3T3 fibroblasts at the transcription and protein levels. CRISPR-mediated disruption of\n                    <jats:italic>Mybpc3<\/jats:italic>\n                    in NIH3T3 fibroblasts activated nuclear factor \u03baB (NF-\u03baB) signaling pathway, which increased the expression of transforming growth factor beta (TGF-\u03b21) and other pro-inflammatory genes. The upregulation of TGF-\u03b21 promoted the expression of hypoxia-inducible factor-1 subunit \u03b1 (HIF-1\u03b1) and its downstream targets involved in glycolysis such as GLUT1, PFK, and LDHA. Consequently, the enhanced aerobic glycolysis with higher rate of ATP biosynthesis accelerated the activation of cardiac fibroblasts, contributing to the development of HCM. This work reveals an intrinsic role of MYBPC3 in maintaining cardiac fibroblast homeostasis and disruption of MYBPC3 in these cells contributes to the disease pathogenesis of HCM.\n                  <\/jats:p>","DOI":"10.1038\/s41419-022-05403-6","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T03:06:38Z","timestamp":1668049598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiaodong","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8327-1281","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-9186","authenticated-orcid":false,"given":"Renzhi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-4832","authenticated-orcid":false,"given":"Xiaochun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"5403_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N. Engl J Med. 2018;379:655\u201368.","journal-title":"N. Engl J Med"},{"key":"5403_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s10741-020-09931-1","volume":"26","author":"ID Muresan","year":"2021","unstructured":"Muresan ID, Agoston-Coldea L. Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging. Heart Fail Rev. 2021;26:1023\u201336.","journal-title":"Heart Fail Rev"},{"key":"5403_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1715","volume":"22","author":"CV Tuohy","year":"2020","unstructured":"Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Hypertrophic cardiomyopathy: the future of treatment. Eur J Heart Fail. 2020;22:228\u201340.","journal-title":"Eur J Heart Fail"},{"key":"5403_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00424-013-1409-7","volume":"466","author":"V Behrens-Gawlik","year":"2014","unstructured":"Behrens-Gawlik V, Mearini G, Gedicke-Hornung C, Richard P, Carrier L. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction. Pflug Arch. 2014;466:215\u201323.","journal-title":"Pflug Arch"},{"key":"5403_CR5","doi-asserted-by":"crossref","unstructured":"Helms AS, Tang VT, O\u2019Leary TS, Friedline S, Wauchope M, Arora A, et al. Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy. JCI Insight. 2020;5:e133782.","DOI":"10.1172\/jci.insight.133782"},{"key":"5403_CR6","doi-asserted-by":"crossref","unstructured":"Da\u2019as SI, Hasan W, Salem R, Younes N, Abdelrahman D, Mohamed IA, et al. Transcriptome profile identifies actin as an essential regulator of cardiac myosin binding protein C3 hypertrophic cardiomyopathy in a zebrafish model. Int J Mol Sci. 2022;23:8840.","DOI":"10.3390\/ijms23168840"},{"key":"5403_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1085\/jgp.201812238","volume":"151","author":"J Giles","year":"2019","unstructured":"Giles J, Patel JR, Miller A, Iverson E, Fitzsimons D, Moss RL. Recovery of left ventricular function following in vivo reexpression of cardiac myosin binding protein C. J Gen Physiol. 2019;151:77\u201389.","journal-title":"J Gen Physiol"},{"key":"5403_CR8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3389\/fphys.2018.01442","volume":"9","author":"E Farrell","year":"2018","unstructured":"Farrell E, Armstrong AE, Grimes AC, Naya FJ, de Lange WJ, Ralphe JC. Transcriptome analysis of cardiac hypertrophic growth in MYBPC3-null mice suggests early responders in hypertrophic remodeling. Front Physiol. 2018;9:1442.","journal-title":"Front Physiol"},{"key":"5403_CR9","doi-asserted-by":"crossref","unstructured":"Murtha LA, Morten M, Schuliga MJ, Mabotuwana NS, Hardy SA, Waters DW, et al. The role of pathological aging in cardiac and pulmonary fibrosis. Aging Dis. 2019;10:419\u201328.","DOI":"10.14336\/AD.2018.0601"},{"key":"5403_CR10","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1002\/jcp.29313","volume":"235","author":"X Meng","year":"2020","unstructured":"Meng X, Wang H, Song X, Clifton AC, Xiao J. The potential role of senescence in limiting fibrosis caused by aging. J Cell Physiol. 2020;235:4046\u201359.","journal-title":"J Cell Physiol"},{"key":"5403_CR11","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Deems Black L. The role of cardiac fibroblasts in extracellular matrix-mediated signaling during normal and pathological cardiac development. J Biomech Eng. 2013;135:71001.","DOI":"10.1115\/1.4024349"},{"key":"5403_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.amjmed.2018.02.025","volume":"131","author":"MS Maron","year":"2018","unstructured":"Maron MS, Chan RH, Kapur NK, Jaffe IZ, McGraw AP, Kerur R, et al. Effect of spironolactone on myocardial fibrosis and other clinical variables in patients with hypertrophic cardiomyopathy. Am J Med. 2018;131:837\u201341.","journal-title":"Am J Med"},{"key":"5403_CR13","doi-asserted-by":"crossref","unstructured":"Kim KK, Sheppard D. Chapman HA. TGF-\u03b21 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10:a022293.","DOI":"10.1101\/cshperspect.a022293"},{"key":"5403_CR14","doi-asserted-by":"crossref","unstructured":"Piersma B, Bank RA. Boersema M. Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge. Front Med (Lausanne). 2015;2:59.","DOI":"10.3389\/fmed.2015.00059"},{"key":"5403_CR15","doi-asserted-by":"crossref","unstructured":"Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H. Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-\u03b2 signaling. Front Cardiovasc Med. 2020;7:34.","DOI":"10.3389\/fcvm.2020.00034"},{"key":"5403_CR16","doi-asserted-by":"crossref","unstructured":"Finnson KW, Almadani Y, Philip A. Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: mechanisms and targets. Semin Cell Dev Biol. 2020;101:115\u201322.","DOI":"10.1016\/j.semcdb.2019.11.013"},{"key":"5403_CR17","doi-asserted-by":"crossref","unstructured":"Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, et al. Diverse roles of TGF\u2010\u03b2 receptor II in renal fibrosis and inflammation in vivo and in vitro. J Pathol. 2012;227:175\u201388.","DOI":"10.1002\/path.3976"},{"key":"5403_CR18","doi-asserted-by":"crossref","unstructured":"Seydelmann N, Liu D, Kr\u00e4mer J, Drechsler C, Hu K, Nordbeck P, et al. High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in Fabry disease. J Am Heart Assoc. 2016;5:e002839.","DOI":"10.1161\/JAHA.115.002839"},{"key":"5403_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.healun.2008.02.018","volume":"27","author":"H Milting","year":"2008","unstructured":"Milting H, Ellinghaus P, Seewald M, Cakar H, Bohms B, Kassner A, et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transpl. 2008;27:589\u201396.","journal-title":"J Heart Lung Transpl"},{"key":"5403_CR20","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","volume":"192","author":"N Xie","year":"2015","unstructured":"Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM, et al. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med. 2015;192:1462\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"5403_CR21","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jcmm.16267","volume":"25","author":"Q Yu","year":"2021","unstructured":"Yu Q, Cheng P, Wu J, Guo C. PPAR\u03b3\/NF-\u03baB and TGF-\u03b21\/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med. 2021;25:1645\u201360.","journal-title":"J Cell Mol Med"},{"key":"5403_CR22","doi-asserted-by":"crossref","unstructured":"Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, et al. TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32:1549\u201359.","DOI":"10.1038\/onc.2012.171"},{"key":"5403_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/jsre.1997.5172","volume":"72","author":"ES Fox","year":"1997","unstructured":"Fox ES, Kim JC, Tracy TF. NF-kappaB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res. 1997;72:129\u201334.","journal-title":"J Surg Res"},{"key":"5403_CR24","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.3892\/mmr.2014.3019","volume":"11","author":"J Zhou","year":"2015","unstructured":"Zhou J, Liang Y, Pan JX, Wang FF, Lin XM, Ma RJ, et al. Protein extracts of Crassostrea gigas alleviate CCl4-induced hepatic fibrosis in rats by reducing the expression of CTGF, TGF-\u03b21 and NF-\u03baB in liver tissues. Mol Med Rep. 2015;11:2913\u201320.","journal-title":"Mol Med Rep"},{"key":"5403_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1177\/0960327112438928","volume":"31","author":"E Ch\u00e1vez","year":"2012","unstructured":"Ch\u00e1vez E, Castro-S\u00e1nchez L, Shibayama M, Tsutsumi V, Moreno MG, Muriel P. Sulfasalazine prevents the increase in TGF-\u03b2, COX-2, nuclear NF\u03baB translocation and fibrosis in CCl4-induced liver cirrhosis in the rat. Hum Exp Toxicol. 2012;31:913\u201320.","journal-title":"Hum Exp Toxicol"},{"key":"5403_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.206","volume":"6","author":"M Zhang","year":"2015","unstructured":"Zhang M, Guo Y, Fu H, Hu S, Pan J, Wang Y, et al. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1\/TLR4\/NF\u03baB\/IL-1\u03b2 signaling. Cell Death Dis. 2015;6:e1847.","journal-title":"Cell Death Dis"},{"key":"5403_CR27","doi-asserted-by":"crossref","unstructured":"Distler JH, J\u00fcngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, et al. Hypoxia\u2010induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum. 2007;56:4203\u201315.","DOI":"10.1002\/art.23074"},{"key":"5403_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599:23\u201337.","journal-title":"J Physiol"},{"key":"5403_CR29","doi-asserted-by":"crossref","unstructured":"Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung Y-L, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 2005;8:143\u201353.","DOI":"10.1016\/j.ccr.2005.06.017"},{"key":"5403_CR30","unstructured":"Jiang B-H, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997;57:5328\u201335."},{"key":"5403_CR31","doi-asserted-by":"crossref","unstructured":"Karni R, Dor Y, Keshet E, Meyuhas O, Levitzki A. Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1\u03b1 expression under normoxia. J Biol Chem. 2002;277:42919\u201325.","DOI":"10.1074\/jbc.M206141200"},{"key":"5403_CR32","unstructured":"Jiang B-H, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK, et al. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 2001;12:363\u201370."},{"key":"5403_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fphar.2017.00326","volume":"8","author":"A Xiong","year":"2017","unstructured":"Xiong A, Liu Y. Targeting hypoxia inducible factors-1\u03b1 as a novel therapy in fibrosis. Front Pharm. 2017;8:326.","journal-title":"Front Pharm"},{"key":"5403_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12079-020-00553-8","volume":"14","author":"R Valle-Tenney","year":"2020","unstructured":"Valle-Tenney R, Rebolledo D, Acu\u00f1a MJ, Brandan E. HIF-hypoxia signaling in skeletal muscle physiology and fibrosis. J Cell Commun Signal. 2020;14:147\u201358.","journal-title":"J Cell Commun Signal"},{"key":"5403_CR35","doi-asserted-by":"publisher","first-page":"24171","DOI":"10.1074\/jbc.M604507200","volume":"281","author":"S McMahon","year":"2006","unstructured":"McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem. 2006;281:24171\u201381.","journal-title":"J Biol Chem"},{"key":"5403_CR36","doi-asserted-by":"crossref","unstructured":"Ung CY, Onoufriadis A, Parsons M, McGrath JA, Shaw TJ. Metabolic perturbations in fibrosis disease. Int J Biochem Cell Biol. 2021;139:106073.","DOI":"10.1016\/j.biocel.2021.106073"},{"key":"5403_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s42255-018-0008-5","volume":"1","author":"X Zhao","year":"2019","unstructured":"Zhao X, Psarianos P, Ghoraie LS, Yip K, Goldstein D, Gilbert R, et al. Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis. Nat Metab. 2019;1:147\u201357.","journal-title":"Nat Metab"},{"key":"5403_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/sj.jid.5701107","volume":"128","author":"AS Vincent","year":"2008","unstructured":"Vincent AS, Phan TT, Mukhopadhyay A, Lim HY, Halliwell B, Wong KP. Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol. 2008;128:702\u20139.","journal-title":"J Invest Dermatol"},{"key":"5403_CR39","doi-asserted-by":"crossref","unstructured":"Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan Q, et al. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am J Physiol Renal Physiol. 2017;313:F561\u2013F75.","DOI":"10.1152\/ajprenal.00036.2017"},{"key":"5403_CR40","doi-asserted-by":"crossref","unstructured":"Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, et al. PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020;100:801\u201311.","DOI":"10.1038\/s41374-020-0404-9"},{"key":"5403_CR41","doi-asserted-by":"crossref","unstructured":"Lee NC, Carella MA, Papa S, Bubici C. High expression of glycolytic genes in cirrhosis correlates with the risk of developing liver cancer. Front Cell Dev Biol. 2018;6:138.","DOI":"10.3389\/fcell.2018.00138"},{"key":"5403_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00018-014-1744-7","volume":"72","author":"XQ Zhou","year":"2015","unstructured":"Zhou XQ, Xin JG, Fan NN, Zou QJ, Huang J, Ouyang Z, et al. Generation of CRISPR\/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci. 2015;72:1175\u201384.","journal-title":"Cell Mol Life Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05403-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T03:06:59Z","timestamp":1668049619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5403"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05403-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1724020\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"948"}}